AI assistant
Sending…
EXELON CORP — Director's Dealing 2023
Oct 3, 2023
30044_dirs_2023-10-02_495d7d6f-35a1-4939-8b73-394498862138.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2023-09-30
Reporting Person: Lillie Charisse R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-30 | Common stock- deferred stock units | A | 1017 | $40.58 | Acquired | 1781 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 7246 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Deferred phantom share equivalents | $ | Common stock (0) | 3515 | Direct |
Footnotes
F1: Balance includes 7 additional shares acquired through automatic dividend reinvestment.
F2: Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
F3: Balance includes 31 additional phantom share equivalents that were accrued to the account by the plan administrator on the ex-dividend date.
More from EXELON CORP
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 16
Annual Report
2026
Mar 18
Regulatory Filings
2026
Mar 18
Proxy Solicitation & Information Statement
2026
Mar 18
Regulatory Filings
2026
Feb 20
Regulatory Filings
2026
Feb 12
Annual Report
2026
Feb 12
Director's Dealing
2026
Feb 4